Notice of Retraction
2022-11-22 18:49
中國神經(jīng)再生研究（英文版） 2022年5期
Retraction: Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
https://doi.org/10.4103/1673-5374.295353 This article has been retracted: please seeNeural Regeneration Research(NRR) Policy on Article Retraction
(http://www.nrronline.org/contributors.asp).
The Editors ofNRRhave retracted the following article entitled “Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia” (2020;15:2217-2234.doi: 10.4103/1673-5374.284981).
An investigation by Drexel University and University of California San Francisco has determined that the study was found using fraudulent affiliations. The author, Michael George Zaki Ghali, cannot provide valid evidence to prove the authenticity of his affiliation. As accurately stating the authorship,affiliated institution, ethics approval and the source of funding is core to the integrity of published work, we are therefore retracting the article. The corresponding author listed in this publication has been informed. The authors did not agree with the decision to retract the article.
- 中國神經(jīng)再生研究（英文版）的其它文章
- Embolic stroke of undetermined source: identification of patient subgroups for oral anticoagulation treatment
- The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets,and therapeutics
- Activity-dependent remodeling of genome architecture in engram cells facilitates memory formation and recall
- Can lithium enhance the extent of axon regeneration and neurological recovery following peripheral nerve trauma?
- Glymphatic imaging and modulation of the optic nerve
- Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury